Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Anti-Thymocyte Globulin Kills Leukemic Stem Cells in Vitro

Rosy Dabas, M.Sc., B.Sc., Poonam Dharmani, PhD, Monica Modi, MD, Tiffany Van Slyke, Joanne Luider, Joseph M. Brandwein, MD FRCPC, Don Morris, Andrew Daly, MD FRCPC, Faisal M Khan, PhD D (ABHI), Jan Storek, MD PhD

Blood (2016) 128 (22): 4616.

https://doi.org/10.1182/blood.V128.22.4616.4616

Published: 2016

Journal Articles

Fludarabine and Busulfan Plus Low Dose TBI Versus Cyclophosphamide Plus TBI in Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia: Equivalent Outcomes in a Recent, Large Canadian Multicenter Cohort

Craig Speziali, MD MSc, FRCPC, Andrew Daly, MD FRCPC, Mohamed Abuhaleeqa, MD, Janet Nitta, Yasser Abou Mourad, MD, Matthew D. Seftel, MBChB, FRCP(C), MRCP, Kristjan Paulson, MD FRCPC

Blood (2016) 128 (22): 663.

https://doi.org/10.1182/blood.V128.22.663.663

Published: 2016

Journal Articles

Evaluation of Varicella Zoster Prophylaxis after Allogeneic Hematopoietic Cell Transplantation Using Valacyclovir Followed By Vaccination

Kareem Jamani, MD, Andrew Daly, MD FRCPC, Jan Storek, MD PhD

Blood (2015) 126 (23): 1963.

https://doi.org/10.1182/blood.V126.23.1963.1963

Published: 2015

Journal Articles

Antithymocyte Globulin at Clinically Relevant Concentration Kills Leukemic Blasts

Rosy Dabas, Rachelle Lee, Maria Theresa Servito, Poonam Dharmani Khan, Monica Modi, MD, Tiffany Van Slyke, Joanne Luider, Caylib Durand, Loree Larratt, MD, Joseph Brandwein, MD FRCPC, Andrew Daly, MD FRCPC, Faisal M Khan, PhD D (ABHI), Jan Storek, MD PhD

Blood (2015) 126 (23): 5481.

https://doi.org/10.1182/blood.V126.23.5481.5481

Published: 2015

Journal Articles

Cytomegalovirus (CMV) Serostatus: High Importance of Choosing Seropositive Donors for Seropositive Patients When Using Rabbit Antithymocyte Globulin (ATG)

Amit Kalra, MBBS, MS, Andrew Daly, MD FRCPC, Jan Storek, MD PhD

Blood (2015) 126 (23): 4402.

https://doi.org/10.1182/blood.V126.23.4402.4402

Published: 2015

Journal Articles

Limited Efficacy of Prompt Therapy of Posttransplant Lymphoproliferative Disorder (PTLD) with Rituximab

Amit Kalra, MBBS, MS, Cameron Roessner, BScPharm, Jennifer Jupp, BScPharm,BCOP, Andrew Daly, MD FRCPC, Jan Storek, MD PhD

Blood (2015) 126 (23): 3114.

https://doi.org/10.1182/blood.V126.23.3114.3114

Published: 2015

Journal Articles

Influence of Fludarabine Pharmacokinetics on Outcome of Allogeneic Stem Cell Transplantation with Fludarabine-Busulfan Conditioning

Mita Manna, MD FRCPC, Andrew Daly, MD FRCPC, Bill Kangarloo, Mary Lynn Savoie, MD FRCPC, Jan Storek, MD PhD

Blood (2015) 126 (23): 3119.

https://doi.org/10.1182/blood.V126.23.3119.3119

Published: 2015

Journal Articles

BK Virus Hemorrhagic Cystitis Is Associated with Graft Versus Host Disease and Increased Health Care Resource Utilization in Patients Undergoing Allogeneic Stem Cell Transplantation

Wilson Lam, MD, Jan Storek, MD PhD, Nizar J Bahlis, MD, Christopher Brown, MD, Peter Duggan, MD FRCPC, Michelle Geddes, MD FRCPC, Mary Lynn Savoie, MD FRCPC, Mona Shafey, MD FRCPC, Douglas A. Stewart, MD FRCPC, Andrew Daly, MD FRCPC

Blood (2014) 124 (21): 3901.

https://doi.org/10.1182/blood.V124.21.3901.3901

Published: 2014

Journal Articles

Fludarabine Metabolite Level On Day Zero Does Not Affect Outcomes Of Hematopoietic Cell Transplantation In Patients With Normal Renal Function

Cameron D. Griffiths, MD, Ella S.M Ng, MSc., Bill Kangarloo, MSc., Tyler S Williamson, PhD, Reanne Booker, BSc, MSN, NP, Ping Yue, MD, Peter Duggan, MD, FRCPC, Mary Lynn Savoie, MD, FRCPC, Christopher Brown, MD, Andrew Daly, MD, FRCPC, James A Russell, MD, Jan Storek, MD, PhD

Blood (2013) 122 (21): 2116.

https://doi.org/10.1182/blood.V122.21.2116.2116

Published: 2013

Journal Articles

Interim Restaging PET/CT-Guided High Dose Sequential Induction Therapy with Autologous Stem Cell Transplantation (ASCT) Does Not Improve Outcome for Poor Prognosis Diffuse Large B-Cell Lymphoma (DLBCL). ClinicalTrials.Gov Identifier: NCT00530179

Douglas A. Stewart, MD, FRCPC, Reinhard Kloiber, MD, FRCPC, Nizar Bahlis, MD, Peter Duggan, MD, FRCPC, Andrew Daly, MD, FRCPC, Christian Fibich, MD, David Blair Macdonald, MD, FRCPC, Isabelle Bence-Bruckler, MD, FRCPC

Blood (2011) 118 (21): 500.

https://doi.org/10.1182/blood.V118.21.500.500

Published: 2011

Journal Articles

Population-Based Study of the Outcomes of Primary Central Nervous System Lymphoma (PCNSL) In the Era of Autologous Stem Cell Transplantation (ASCT)

Carolyn J Owen, MD, FRCPC, Andrew Daly, MD, FRCPC, Neil Chua, MD, FRCPC, Douglas A. Stewart, MD, FRCP

Blood (2010) 116 (21): 1346.

https://doi.org/10.1182/blood.V116.21.1346.1346

Published: 2010

Journal Articles

Autologous Stem Cell Transplantation Is a Curative Treatment Modality for Relapsed or Refractory Follicular Lymphoma, and Both Recent Rituximab Exposure and Follicular Lymphoma International Prognostic Index (FLIPI) 0–1 Scores Predict Improved Outcome

Anthea Peters, MD, MSc, FRCPC, James A Russell, MD, Andrew Daly, MD, FRCPC, Nizar J Bahlis, MD, Michelle Geddes, MD, Peter Duggan, MD, FRCPC, Mary Lynn Savoie, MD, FRCPC, Douglas A. Stewart, MD, FRCP

Blood (2010) 116 (21): 687.

https://doi.org/10.1182/blood.V116.21.687.687

Published: 2010

Journal Articles

FluBup-ATG-TBI for High-Risk or Advanced Adult ALL in Remission: A Retrospective Review of a Mature Cohort.

Andrew Daly, MD, FRCPC, Douglas A. Stewart, MD, FRCPC, Ahsan Chaudhry, MD, Nizar J Bahlis, MD, FRCPC, Christopher Brown, MD, FRCPC, Peter Duggan, MD, FRCPC, Michelle Geddes, MD, FRCPC, Mary Lynn Savoie, MD, FRCPC, Jan Storek, MD, PhD, Maggie Yang, James A. Russell, MD, FRCPC

Blood (2009) 114 (22): 3384.

https://doi.org/10.1182/blood.V114.22.3384.3384

Published: 2009

Journal Articles

Interim Restaging FDG-PET/CT to Guide Use of High Dose Sequential Induction Therapy with Rituximab-Dose-Intensive Cyclophosphamide, Etoposide, Cisplatin (RDICEP) and Rituximab-Carmustine, Etoposide, Cytarabine, Melphalan (RBEAM) and Autologous Stem Cell Transplantation (ASCT) for Poor Prognosis Diffuse Large B-Cell Lymphoma (DLBCL). ClinicalTrials. Gov Identifier: NCT00530179.

Douglas A. Stewart, MD, FRCPC, Peter Duggan, MD, FRCPC, Nizar J Bahlis, MD, Andrew Daly, MD, FRCPC, Michelle Geddes, MD, FRCPC, Reinhard Kloiber, MD, FRCPC, Christian Fibich, MD, David Blair Macdonald, MD, FRCPC, Isabelle Bence-Bruckler, MD, FRCPC

Blood (2009) 114 (22): 3414.

https://doi.org/10.1182/blood.V114.22.3414.3414

Published: 2009

NARROW

Anti-Thymocyte Globulin Kills Leukemic Stem Cells in Vitro

Fludarabine and Busulfan Plus Low Dose TBI Versus Cyclophosphamide Plus TBI in Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia: Equivalent Outcomes in a Recent, Large Canadian Multicenter Cohort

Evaluation of Varicella Zoster Prophylaxis after Allogeneic Hematopoietic Cell Transplantation Using Valacyclovir Followed By Vaccination

Antithymocyte Globulin at Clinically Relevant Concentration Kills Leukemic Blasts

Cytomegalovirus (CMV) Serostatus: High Importance of Choosing Seropositive Donors for Seropositive Patients When Using Rabbit Antithymocyte Globulin (ATG)

Limited Efficacy of Prompt Therapy of Posttransplant Lymphoproliferative Disorder (PTLD) with Rituximab

Influence of Fludarabine Pharmacokinetics on Outcome of Allogeneic Stem Cell Transplantation with Fludarabine-Busulfan Conditioning

BK Virus Hemorrhagic Cystitis Is Associated with Graft Versus Host Disease and Increased Health Care Resource Utilization in Patients Undergoing Allogeneic Stem Cell Transplantation

Fludarabine Metabolite Level On Day Zero Does Not Affect Outcomes Of Hematopoietic Cell Transplantation In Patients With Normal Renal Function

Interim Restaging PET/CT-Guided High Dose Sequential Induction Therapy with Autologous Stem Cell Transplantation (ASCT) Does Not Improve Outcome for Poor Prognosis Diffuse Large B-Cell Lymphoma (DLBCL). ClinicalTrials.Gov Identifier: NCT00530179

Population-Based Study of the Outcomes of Primary Central Nervous System Lymphoma (PCNSL) In the Era of Autologous Stem Cell Transplantation (ASCT)

Autologous Stem Cell Transplantation Is a Curative Treatment Modality for Relapsed or Refractory Follicular Lymphoma, and Both Recent Rituximab Exposure and Follicular Lymphoma International Prognostic Index (FLIPI) 0–1 Scores Predict Improved Outcome

FluBup-ATG-TBI for High-Risk or Advanced Adult ALL in Remission: A Retrospective Review of a Mature Cohort.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only